About this trial
Children with short stature have been reported to show a higher prevalence of enamel hypoplasia, delayed tooth eruption, and malocclusion compared to children of normal growth status
Eligibility criteria
This trial accepts healthy volunteersQualifiers
• - Egyptian children aged 6-12 years.
- Diagnosed with short stature (height-for-age < -2 SD based on WHO standards).
- Diagnosed and confirmed by a pediatric endocrinologist.
- Age- and sex-matched children with normal height (height-for-age between -1 and +1 SD).
Disqualifiers
1- Presence of syndromic conditions (e.g., Turner syndrome, Down syndrome).
2- Chronic diseases (e.g., renal, cardiac, or endocrine conditions other than idiopathic short stature).
3- Long-term medication use known to affect growth or oral development.
Trial population
Children aged from 6 to 12 years attending National Nutrition Institute will be included in the study according to the following criteria:
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Dental enamel defects
using Aine's classification
Delayed dental eruption
using Dental eruption table
Malocclusion
using Angle classification
Dental caries experience
using def+DMF
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: